Abstract
RESTORE Study: Effects of a 24-Week Natalizumab Treatment Interruption on Immune Parameters and Multiple Sclerosis Magnetic Resonance Imaging Disease Activity (P06.168)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have